TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Micro-X Ltd. ( (AU:MX1) ) just unveiled an update.
Micro-X Ltd., a leader in cold cathode X-ray technology, announced it received a $5.08 million R&D Tax Incentive from the Australian Tax Office for the financial year ending June 2025. This rebate, which supports the company’s R&D activities, was used to repay a previously accessed funding facility. Micro-X is also seeking an additional $0.31 million through an amendment, potentially increasing the total R&D rebate to $5.39 million. This financial boost aligns with the company’s guidance and supports its ongoing innovation in health and security markets, potentially enhancing its market position and stakeholder value.
The most recent analyst rating on (AU:MX1) stock is a Buy with a A$0.17 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.
More about Micro-X Ltd.
Micro-X Limited is an ASX-listed high-tech company specializing in the development and commercialization of innovative products for global health and security markets. The company utilizes proprietary cold cathode, carbon nanotube (CNT) emitter technology to create x-ray products that are smaller, lighter, and require less power, enhancing mobility and usability. Micro-X operates a fully integrated design and production facility in Adelaide, Australia, and has a growing team in Seattle to expand its US business. Its product portfolio includes mobile digital radiology products for healthcare, military, and veterinary applications, as well as security solutions and medical imaging technologies.
Average Trading Volume: 430,936
Technical Sentiment Signal: Buy
Current Market Cap: A$66.78M
Learn more about MX1 stock on TipRanks’ Stock Analysis page.